
Keywords: Multi-target; Morpholine; Benzoxazine; Benzothiazine; Antioxidant; Squalene synthase; Hyperlipidemia; Triglycerides; Antiatherogenic index; CVD; Cardiovascular disease; SQS; squalene synthase; HMG-CoA; 3-hydroxy-3-methylglutaryl-CoA; FPP; farnesyl pyropho